We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
560
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRT
3726
DELISTED
Startek Inc.
SRT
$75K ﹤0.01%
26,232
+9,931
+61% +$36.8K
KDNY
3727
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$75K ﹤0.01%
4,337
-4,053
-48% -$63.6K
GSK icon
3728
GSK
GSK
$106B
$74K ﹤0.01%
1,377
-1,200
-47% -$66.2K
ROIV icon
3729
Roivant Sciences
ROIV
$26.2B
$74K ﹤0.01%
18,115
+7,535
+71% +$29.9K
VERV
3730
DELISTED
Verve Therapeutics
VERV
$74K ﹤0.01%
4,856
-20,139
-81% -$312K
CFB
3731
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$74K ﹤0.01%
5,647
-2,057
-27% -$27.7K
CERE
3732
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$74K ﹤0.01%
2,815
-4,002
-59% -$114K
HLAHU
3733
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Unit
HLAHU
$74K ﹤0.01%
7,549
-753
-9% -$7.43K
ALTO icon
3734
Alto Ingredients
ALTO
$340M
$73K ﹤0.01%
19,843
+6,044
+44% +$31.6K
IONQ icon
3735
IonQ
IONQ
$16.6B
$73K ﹤0.01%
16,686
-51,702
-76% -$366K
IWP icon
3736
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$73K ﹤0.01%
920
TMCI icon
3737
Treace Medical Concepts
TMCI
$309M
$73K ﹤0.01%
5,068
-3,282
-39% -$55.3K
GDEV
3738
DELISTED
Nexters Inc. Ordinary Shares
GDEV
$73K ﹤0.01%
11,418
DH icon
3739
Definitive Healthcare
DH
$75.3M
$72K ﹤0.01%
3,141
+2,809
+846% +$60.1K
DOO
3740
Bombardier Recreational Products
DOO
$4.77B
$72K ﹤0.01%
1,183
-65
-5% -$4.86K
KRON
3741
DELISTED
Kronos Bio
KRON
$72K ﹤0.01%
19,877
+9,609
+94% +$43.6K
SIGA icon
3742
SIGA Technologies
SIGA
$219M
$72K ﹤0.01%
6,238
-1,802
-22% -$16.2K
SPHR icon
3743
Sphere Entertainment
SPHR
$5.73B
$72K ﹤0.01%
1,366
-3,173
-70% -$214K
EZU icon
3744
iShare MSCI Eurozone ETF
EZU
$9.91B
$71K ﹤0.01%
1,941
INSG icon
3745
Inseego
INSG
$90.5M
$71K ﹤0.01%
3,758
+409
+12% +$10.4K
TYO icon
3746
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$12.4M
$71K ﹤0.01%
6,182
BWIN
3747
Baldwin Insurance Group
BWIN
$2.86B
$71K ﹤0.01%
2,934
-5,540
-65% -$135K
ISPO
3748
DELISTED
Inspirato
ISPO
$70K ﹤0.01%
+764
New +$88.1K
JYNT icon
3749
The Joint Corp
JYNT
$119M
$70K ﹤0.01%
4,534
-6,898
-60% -$154K
PVLA
3750
Palvella Therapeutics
PVLA
$2.27B
$70K ﹤0.01%
466
-508
-52% -$92.7K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 560 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.